US 8735452
Treating patients with intravenous ibuprofen
granted A61KA61K31/19A61K31/192
Quick answer
US patent 8735452 (Treating patients with intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/19, A61K31/192, A61K31/198, A61K9/0019